[4P-0118] Application to optimized cancer treatment using cancer cells with atypical DNA repair pathway activation after cancer treatments
RECQL4, RAD52 inhibitor, error-prone DNA repair, targeted therapy, genomic instability
This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.